Back to Journals » Therapeutics and Clinical Risk Management » Volume 15

Chronic eosinophilic pneumonia: clinical perspectives

Authors Crowe M, Robinson D, Sagar M, Chen L, Ghamande S

Received 17 October 2018

Accepted for publication 19 January 2019

Published 13 March 2019 Volume 2019:15 Pages 397—403


Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Professor Garry Walsh

Matthew Crowe,1 Drew Robinson,2 Malvika Sagar,3 Li Chen,4 Shekhar Ghamande1

1Department of Medicine, Division of Pulmonary and Critical Care, Baylor Scott and White Medical Center, Temple, TX, USA; 2Department of Medicine, Baylor Scott and White Medical Center, Temple, TX, USA; 3Department of Pediatrics, Baylor Scott and White McLane Children’s Specialty Clinic Temple, Temple, TX, USA; 4Department of Pathology, Baylor Scott and White Medical Center Temple, Temple, TX, USA

Abstract: Chronic eosinophilic pneumonia (CEP) is an eosinophilic lung disease that is typically diagnosed by a triad of clinical symptoms including pulmonary symptoms, eosinophilia and characteristic radiographic abnormalities. It requires a high index of suspicion given its overlap with other eosinophilic conditions and lack of a specific diagnostic test. The diagnosis is made after careful consideration of other secondary causes of eosinophilia, such as infectious, drugs, or toxic etiologies. CEP generally responds rapidly to treatment, which primarily consists of corticosteroid therapy, but relapses are common. Novel therapies are being explored as more information is being discovered about the pathophysiology of eosinophilic disease processes. Close follow-up is important given the difficulty in weaning patients from glucocorticoids with many patients developing sequelae of chronic glucocorticoid therapy. Therefore, exploring alternative treatments is of upmost importance.

Keywords: eosinophilic, mepolizumab, infiltrates, BAL, IL-5, lung, prednisone

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]